MRI LAVA扫描技术评估布-加综合征患者侧支循环研究*

doi:10.3969/j.issn.1672-5069.2022.05.021

实用肝脏病杂志 ›› 2022, Vol. 25 ›› Issue (5): 689-692.doi: 10.3969/j.issn.1672-5069.2022.05.021

MRI LAVA扫描技术评估布-加综合征患者侧支循环研究^*

黄娟, 张吉琛

435000 湖北省黄石市湖北理工学院附属鄂东医疗集团黄石市中心医院放射影像科

收稿日期:2022-04-18 出版日期:2022-09-10 发布日期:2022-09-22
通讯作者: 张吉琛,E-mail:haohao18362022@163.com
作者简介:黄娟,女,42岁,大学本科,主管技师。E-mail:yaya06632022@163.com
基金资助:
湖北省自然科学基金资助项目(编号:2016CFB638)

MRI LAVA scanning for collateral circulation in patients with Budd-Chiari syndrome

Huang Juan, Zhang Jichen

Department of Radiology, Huangshi Central Hospital, East Hubei Medical Group, Affiliated to Hubei College of Technology, Huangshi 435000, Hubei Province, China

Received:2022-04-18 Online:2022-09-10 Published:2022-09-22

摘要/Abstract

摘要： 目的分析采用磁共振成像(MRI)肝脏加速容积采集(LAVA)扫描技术评估布-加综合征(BCS)患者侧支循环的效果。方法 2017年3月～2022年3月我院收治的BCS患者47例,均接受数字减影血管造影(DSA)和MRI检查。以DSA检查结果为“金标准”,判断MRI LAVA对BCS分型诊断的准确率。结果 DSA检查诊断肝静脉阻塞型BCS 18例,下腔静脉阻塞型BCS 21例和混合型BCS 8例,而MRI LAVA诊断肝静脉阻塞型16例,下腔静脉阻塞型21例,混合型10例,其准确性为95.7%;在47例BCS患者中,MRI LAVA显示膈下静脉扩张9例(19.1%),肝内交通支扩张12例(25.5%),腹壁浅静脉扩张26例(55.3%),副肝静脉扩张26例(55.3%),奇/半奇静脉扩张39例(83.0%);与DSA检查比,MRI LAVA显示副肝静脉的准确性为100%。结论采用MRI LAVA扫描技术能够准确判断BCS分型,观察不同类型侧支循环建立情况,为临床诊疗提供依据。

关键词: 布-加综合征, 磁共振成像, 肝脏加速容积采集技术, 侧支循环, 诊断

Abstract: Objective The aim of this study was to analyze the magnetic resonance imaging (MRI) with accelerated volume acquisition (LAVA) technology in evaluating collateral circulation in patients with Budd-Chiari syndrome (BCS). Methods 47 patients with BCS were admitted to our hospital between March 2017 and March 2022, and all underwent digital subtraction angiography (DSA) and MRI scan. The DSA results acted as the "gold standard" to determine the accuracy(Ac) of MRI LAVA on BCS typing and the collateral circulation. Results Among the 47 patients with BCS, the DSA showed hepatic vein occlusion in 18 cases, inferior vena cava occlusion in 21 cases, and mixed type in 8 cases, and the MRI LAVA found hepaticvein occlusion in 16 cases, inferior vena cava occlusion in 21 cases, and mixed occlusion in 10 cases,with the Ac of 95.7%; the MRI LAVA also showed inferior phrenic vein dilatation in 9 cases(19.1%), the intrahepatic communicating branch in 12 cases (25.5%), the superficial abdominal vein dilatation in 26 cases(55.3%), the accessory hepatic vein in 26 cases(55.3%), the azygos/hemiazygos vein in 39 cases(83.0%); the Ac in demonstrating accessory hepatic vein by MRI LAVA was 100%, as compared to by DSA. Conclusion The MRI LAVA scanning could accurately determine the classification of BCS and the collateral circulation establishment, which might guide the clinicians for appropriate management.

Key words: Budd-Chiari syndrome, Magnetic resonance imaging, Liver acceleration volume acquisition technique, Collateral circulation, Diagnosis

黄娟, 张吉琛. MRI LAVA扫描技术评估布-加综合征患者侧支循环研究^*[J]. 实用肝脏病杂志, 2022, 25(5): 689-692.

Huang Juan, Zhang Jichen. MRI LAVA scanning for collateral circulation in patients with Budd-Chiari syndrome[J]. Journal of Practical Hepatology, 2022, 25(5): 689-692.

参考文献

[1]Sharma A, Keshava SN, Eapen A, et al. An update on the management of Budd-Chiari syndrome. Dig Dis Sci, 2021, 66(6):1780-1790.
[2]Shukla A, Shreshtha A, Mukund A, et al. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int, 2021, 15(3):531-567.
[3]Inchingolo R, Posa A, Mariappan M, et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: a comprehensive review. World J Gastroenterol, 2020, 26(34):5060-5073.
[4]Lu X, Ma X, Xu K, et al. Inferior vena cava obstruction in Budd-Chiari syndrome: a comparative study of rapid quantitative phase-contrast MRI and MRV. Abdom Radiol (NY), 2020, 45(4):1069-1074.
[5]吴磊, 姚群立, 祖茂衡, 等. 布加综合征患者侧支循环类型与肝功能Child分级的相关性研究. 中华普通外科杂志, 2018, 33(2):118-121.
[6]中华医学会放射学分会介入学组. 布-加综合征介入诊疗规范的专家共识. 中华放射学杂志, 2010, 44(4):345-349.
[7]中国医师协会腔内血管学专业委员会腔静脉阻塞专家委员会. 布-加综合征亚型分型的专家共识. 介入放射学杂志, 2017, 26(3):195-201.
[8]Alukal JJ, Zhang T, Thuluvath PJ. A nationwide analysis of Budd-Chiari syndrome in the United States. J Clin Exp Hepatol, 2021, 11(2):181-187.
[9]Haque LYK, Lim JK. Budd-Chiari syndrome: an uncommon cause of chronic liver disease that cannot be missed. Clin Liver Dis, 2020, 24(3):453-481.
[10] Siddique M, Iqbal A, Sultan Rai AB. Budd-Chiari syndrome computed tomographic imaging: elucidating the devil in the details. J Pak Med Assoc, 2021, 71(7):1889-1892.
[11] Panvini N, Dioguardi Burgio M, Sartoris R, et al. MR imaging features and long-term evolution of benign focal liver lesions in Budd-Chiari syndrome and Fontan-associated liver disease. Diagn Interv Imaging, 2022, 103(2):111-120.
[12] Shalimar AG, Sharma S, Gamanagatti SR, et al. Acute-on-chronic liver failure in Budd-Chiari syndrome: profile and predictors of outcome. Dig Dis Sci, 2020, 65(9):2719-2729.
[13] Irie R, Amemiya S, Ueyama T, et al. Accelerated acquisition of carotid MR angiography using 3D gradient-echo imaging with two-point Dixon. Neuroradiology, 2020, 62(10):1345-1349.
[14] Van Wettere M, Bruno O, Rautou PE, et al. Diagnosis of Budd-Chiari syndrome. Abdom Radiol (NY), 2018, 43(8):1896-1907.
[15] Valla DC. Budd-Chiari syndrome/hepatic venous outflow tract obstruction. Hepatol Int, 2018, 12(1):168-180.
[16] Das CJ, Soneja M, Tayal S, et al. Role of radiological imaging and interventions in management of Budd-Chiari syndrome. Clin Radiol, 2018, 73(7):610-624.
[17] Khan F, Armstrong MJ, Mehrzad H, et al. A multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Aliment Pharmacol Ther, 2019, 49(7):840-863.
[18] Lyu LL, Zhu LL, Chen GH, et al. Recanalization of accessory hepatic vein for hepatic vein-type Budd-Chiari syndrome. Abdom Radiol (NY), 2021, 46(7):3456-3463.
[19] Li DM, Yin X, Yang F, et al. Accessory hepatic vein recanalization for hepatic vein-type Budd-Chiari syndrome. Minim Invasive Ther Allied Technol, 2021, 30(4):239-244.
[20] Lu L, Xu K, Han C, et al. Comparison of 3.0T MRI with 3D LAVA sequence and digital subtraction angiography for the assessment of accessory hepatic veins in Budd-Chiari syndrome. J Magn Reson Imaging, 2017, 45(2):401-409.

MRI LAVA扫描技术评估布-加综合征患者侧支循环研究^*

MRI LAVA scanning for collateral circulation in patients with Budd-Chiari syndrome

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	罗楠, 李荣宽. 肝硬化并发自发性细菌性腹膜炎诊治现状[J]. 实用肝脏病杂志, 2022, 25(5): 616-619.
[2]	米朦, 卢秉久, 王学良, 王晓彤, 郑佳连. 代谢相关性脂肪性肝病患者血脂分析^*[J]. 实用肝脏病杂志, 2022, 25(5): 653-656.
[3]	骆苏彦, 李婷婷, 王亚奇, 齐林. 原发性胆汁性胆管炎患者外周血Treg/Th17细胞相关细胞因子水平变化^*[J]. 实用肝脏病杂志, 2022, 25(5): 673-676.
[4]	龚豪, 黄丽, 张庆红, 李涛, 史秀岩. 应用尿微量白蛋白、β2-微球蛋白和N-乙酰-β-D氨基葡萄糖苷酶评估失代偿期肝硬化患者肾损伤效能研究^*[J]. 实用肝脏病杂志, 2022, 25(5): 681-684.
[5]	施莹, 柏根基, 孙阳. 多模态MRI对肝硬化增生性结节与小肝癌的鉴别诊断价值探讨^*[J]. 实用肝脏病杂志, 2022, 25(5): 722-725.
[6]	杨静, 程艳丽. 特发性非肝硬化性门脉高压1例并文献复习[J]. 实用肝脏病杂志, 2022, 25(5): 750-752.
[7]	中国医药生物技术协会慢病管理分会. 肝硬化合并糖尿病患者血糖管理专家共识[J]. 实用肝脏病杂志, 2022, 25(5): 761-S1.
[8]	陈梦绮, 范建高. 美国非酒精性脂肪性肝病诊断与治疗临床实践指南简介^*[J]. 实用肝脏病杂志, 2022, 25(5): 762-S16.
[9]	莫金英, 余希, 余雪平, 吴丽华, 瞿志军. FibroTouch诊断乙型肝炎病毒携带者肝纤维化价值研究^*[J]. 实用肝脏病杂志, 2022, 25(4): 480-483.
[10]	罗真真, 田海英, 葛建华, 纪元. 慢性丙型肝炎患者血清N-寡糖和胆汁酸水平变化判断肝纤维化临床价值分析^*[J]. 实用肝脏病杂志, 2022, 25(4): 504-507.
[11]	付丽红, 高月求, 王晓琳, 刘坤, 李曼, 黄凌鹰. 38例药物性肝损伤患者肝组织病理学特征分析^*[J]. 实用肝脏病杂志, 2022, 25(4): 512-516.
[12]	汤磊, 彭蕾, 叶珺, 张振华, 邹桂舟. 影响慢性乙型肝炎患者进展为肝硬化的多因素分析^*[J]. 实用肝脏病杂志, 2022, 25(4): 538-541.
[13]	李芳, 王衍森, 翁璐昕. 高频超声肝实质纹理特征定量联合血清AFP-L3水平评估乙型肝炎肝硬化患者肝功能分级价值研究^*[J]. 实用肝脏病杂志, 2022, 25(4): 542-545.
[14]	郑丽雅, 田澄, 李娜. 剪切波弹性成像技术联合多参数评估肝硬化患者食管静脉曲张价值研究^*[J]. 实用肝脏病杂志, 2022, 25(4): 546-549.
[15]	王宝锋, 马彦高, 李义, 曾宪强, 周进学. 增强MRI扫描在乙型肝炎肝硬化背景下对原发性肝癌的诊断价值分析^*[J]. 实用肝脏病杂志, 2022, 25(4): 554-557.